Mathews, Roshan Pathitharayil
Habibagahi, Iman
Jafari Sharemi, Hamid
Challita, Ronald
Cha, Steven
Babakhani, Aydin
Funding for this research was provided by:
National Institutes of Health
Article History
Received: 24 February 2025
Accepted: 8 July 2025
First Online: 30 July 2025
Declarations
:
: Aydin Babakhani is co-founder of Maxwell Biomedical Inc and Nervonik. Other authors declare no competing interests.